Sustaining Weight Loss: What Is The Most Common Maintenance Dose Of Mounjaro?

Last reviewed: July 10, 2026

Last updated: July 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

After weeks or months of progressive dosing, many patients ask: when do I stop increasing my tirzepatide dose? The answer depends on reaching your personal weight loss plateau—the point where your body and metabolism respond optimally. Unlike a one-size-fits-all protocol, finding your maintenance dose is a gradual, personalized process guided by clinical response and metabolic markers.

What Is A Maintenance Dose On Tirzepatide?

A maintenance dose is the steady, ongoing amount of medication you take once your weight has stabilized at or near your target. For tirzepatide (Mounjaro), this typically falls between 5 mg and 15 mg injected once weekly. Rather than continuing to increase your dose every 4 weeks, your provider identifies the lowest effective dose that keeps your appetite regulated and weight stable without unnecessary side effects.

The maintenance phase usually begins after you've reached a plateau in weight loss—a natural point where your body adapts to the medication. At this stage, increasing your dose further may offer diminishing returns or introduce unwanted gastrointestinal effects. Your role is to communicate honestly with your care provider about your current weight, hunger levels, and overall tolerability so they can lock in the right maintenance dose for you.

Clinical Evidence On Typical Tirzepatide Maintenance Doses

Major clinical trials revealed that most participants achieved meaningful weight loss and then remained on doses ranging from 10 mg to 15 mg weekly. In the SURMOUNT-1 trial, the 15 mg dose produced sustained weight loss of approximately 22% over 68 weeks, and patients who remained on that dose did not regain weight during the maintenance phase. This suggests that once a therapeutic dose is found, consistency matters more than continuous escalation.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Mounjaro or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How PlexusDx Personalizes Your Maintenance Dose Strategy

PlexusDx Compounded Tirzepatide Injection starts at $289/mo (or $249/mo on the 6-month plan) with no flat per-compound pricing increases—your dose may need to go up, but your price won't. This flat-rate model removes financial barriers to finding your true maintenance dose without fear of escalating costs. PlexusDx serves all 50 states with no insurance required, no membership fee, and HSA/FSA eligibility, making precision tirzepatide therapy accessible.

The Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights—including variants in GLP1R (rs6923761), GIPR (rs1800437), and FTO (rs9939609) that influence tirzepatide response. This genetic roadmap helps your PlexusDx provider anticipate whether you're likely to succeed on a lower maintenance dose or require a higher one, reducing trial-and-error adjustments. The test is performed by licensed 503A compounding pharmacies, ensuring clinical accuracy and personalization.

Transitioning From Titration To Stable Maintenance

The transition from dosing up to staying stable typically takes 12 to 16 weeks. During this period, you increase your tirzepatide dose every 4 weeks (0.5 mg → 1 mg → 2.5 mg → 5 mg → 7.5 mg → 10 mg, then optionally to 15 mg). Your provider monitors your weight loss velocity, hunger cues, and side effect burden at each step. Once you've hit a weekly weight loss rate that feels sustainable and your appetite suppression is strong without nausea or fatigue, you've likely found your maintenance zone.

Staying on your maintenance dose for at least 4 to 8 weeks before any further adjustment allows your body to fully adapt and your weight to truly stabilize. Some patients remain on maintenance indefinitely; others may taper or take breaks under medical supervision. PlexusDx recommends consistent weekly check-ins during the first month and monthly assessments thereafter, with your provider adjusting your dose only if your weight begins to creep upward or side effects become problematic. Compounded formulations from licensed 503A pharmacies ensure batch consistency and purity, critical for reliable dosing accuracy.

Weight Regain And Long-Term Maintenance Strategies

Research shows that stopping tirzepatide leads to weight regain in most patients within 6 to 12 months—a finding that underscores why long-term maintenance dosing is the standard of care. Staying on your maintenance dose preserves the metabolic and appetite-control benefits, preventing the yo-yo cycle many experience with short-term weight loss approaches. Your maintenance dose becomes your new equilibrium, much like ongoing blood pressure or diabetes management.

To optimize long-term success, combine your tirzepatide maintenance dose with consistent eating patterns, regular movement, and periodic metabolic assessments. Some PlexusDx patients benefit from the Microdose GLP-1 Protocol ($129/mo flat rate) as an alternative entry point or adjunct, especially if side effects emerge on standard tirzepatide doses. Your care team will recommend whether your maintenance should involve oral tirzepatide, injectable tirzepatide, or even dual-compound GLP-Squared formulations based on your tolerance and results. The goal is finding the sustainable dose—and lifestyle—that works for your body long-term.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the most common maintenance dose of Mounjaro that patients stay on?

Most patients maintain their weight loss on tirzepatide doses between 7.5 mg and 15 mg injected weekly. The exact dose depends on your individual metabolism, starting body weight, and metabolic response. PlexusDx helps identify your personalized maintenance dose through genetic testing and gradual titration monitoring.

Will my weight loss continue if I stay on the same tirzepatide dose?

Once you reach your maintenance dose, weight loss typically slows or plateaus—which is the expected signal that you've found the right dose for your body. Staying stable on your maintenance dose preserves the weight you've lost and prevents regain, rather than driving continuous additional loss. Clinical trials show sustained weight maintenance for 12+ months on consistent doses.

How much does compounded tirzepatide cost at PlexusDx, and does it vary with my dose?

PlexusDx Compounded Tirzepatide Injection starts at $289/mo (or $249/mo on the 6-month plan) with a flat rate across all dose levels—your dose may need to go up, but your price won't. No insurance is required, and the medication is HSA/FSA eligible and available in all 50 states.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. PlexusDx Precision Peptide Genetic Test ($99 after your first month) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to tirzepatide. This genetic insight helps your provider anticipate whether you'll succeed on a lower or higher maintenance dose, reducing guesswork.

What happens if my weight starts creeping back up while on maintenance?

If regain occurs, your PlexusDx provider may increase your maintenance dose by 1–2 mg or optimize your lifestyle factors (eating patterns, movement, sleep). Staying on tirzepatide long-term is the most effective way to prevent regain; stopping the medication typically leads to weight return within 6–12 months.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.